Literature DB >> 32459313

Weight-Based Dosing of Pembrolizumab Every 6 Weeks in the Time of COVID-19.

Daniel A Goldstein1,2, Mark J Ratain3, Leonard B Saltz4.   

Abstract

Entities:  

Year:  2020        PMID： 32459313     DOI： 10.1001/jamaoncol.2020.2493

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  6 in total

1.  Adoption of Extended-Interval Dosing of Single-Agent Pembrolizumab and Comparative Effectiveness vs Standard Dosing in Time-to-Treatment Discontinuation.

Authors:  Garth W Strohbehn; Robert Holleman; Jennifer Burns; Mandi L Klamerus; Michael J Kelley; Eve A Kerr; Nithya Ramnath; Timothy P Hofer
Journal:  JAMA Oncol       Date:  2022-09-22       Impact factor: 33.006

Review 2.  Severity of COVID-19 in patients with lung cancer: evidence and challenges.

Authors:  Antonio Passaro; Christine Bestvina; Maria Velez Velez; Marina Chiara Garassino; Edward Garon; Solange Peters
Journal:  J Immunother Cancer       Date:  2021-03       Impact factor: 13.751

Review 3.  Immunotherapy and Radiotherapy for Older Cancer Patients during the COVID-19 Era: Proposed Paradigm by the International Geriatric Radiotherapy Group.

Authors:  Nam Phong Nguyen; Brigitta G Baumert; Eromosele Oboite; Micaela Motta; Gokula Kumar Appalanaido; Meritxell Arenas; Pedro Carlos Lara; Marta Bonet; Alice Zamagni; Te Vuong; Tiberiu Popescu; Ulf Karlsson; Lurdes Trigo; Arthur Sun Myint; Juliette Thariat; Vincent Vinh-Hung
Journal:  Gerontology       Date:  2021-03-30       Impact factor: 5.140

Review 4.  Dosing Regimens of Immune Checkpoint Inhibitors: Attempts at Lower Dose, Less Frequency, Shorter Course.

Authors:  Mengjie Jiang; Yujie Hu; Gang Lin; Chao Chen
Journal:  Front Oncol       Date:  2022-06-20       Impact factor: 5.738

5.  The influence of delayed treatment due to COVID-19 on patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Xinyu Zhao; Lihui Meng; Mingyue Luo; Weihong Yu; Hanyi Min; Rongping Dai; Adrian Koh; Youxin Chen
Journal:  Ther Adv Chronic Dis       Date:  2021-06-22       Impact factor: 5.091

Review 6.  Cancer Immunotherapy Dosing: A Pharmacokinetic/Pharmacodynamic Perspective.

Authors:  Félicien Le Louedec; Fanny Leenhardt; Clémence Marin; Étienne Chatelut; Alexandre Evrard; Joseph Ciccolini
Journal:  Vaccines (Basel)       Date:  2020-10-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.